Dr. Tomlinson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4502 Medical Drive
10th Floor Horizon Tower
San Antonio, TX 78229Phone+1 210-743-2300Fax+1 210-702-6012
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 1989 - 1992
- Children's National HospitalResidency, Pediatrics, 1984 - 1987
- George Washington University School of Medicine and Health SciencesClass of 1984
Certifications & Licensure
- TX State Medical License 1989 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
Publications & Presentations
PubMed
- 230 citationsCharacterization of paired tumor and non-tumor cell lines established from patients with breast cancerAdi F. Gazdar, Venkatesh Kurvari, Arvind K. Virmani, Lauren S. Gollahon, Masahiro Sakaguchi
International Journal of Cancer. 1998-12-09 - 99 citationsThe Impact of COVID-19 on Cancer Screening: Challenges and Opportunities.Ramon S. Cancino, Zhaohui Su, Ruben A. Mesa, Gail E. Tomlinson, Jing Wang
JMIR Cancer. 2020-10-29 - 1008 citationsAssociation of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalitySusan M. Domchek, Tara M. Friebel, Christian F. Singer, D. Gareth Evans, Henry T. Lynch
JAMA. 2010-09-01
Press Mentions
- Experts Support Continued Colonoscopy Use to Prevent and Detect Colorectal CancerOctober 28th, 2022
- UT Health San Antonio Snags $11 Million to Fight CancerFebruary 19th, 2022
- Do All Chemotherapies Have Equal Long-Term Heart Risk?January 31st, 2019
Grant Support
- Correlative Genetic Markers In Childhood HepatoblastomaNational Cancer Institute2008–2009
- Serum Markers Of Angiogenesis In Von Hippel-Lindau Dise*National Cancer Institute2005
- Serum Markers /Angiogenesis In Von Hippel-Lindau DiseaseNational Cancer Institute2004
- Phenotypic Risk Markers In BRCA1 Mutation CarriersNational Cancer Institute2001–2002
- Genetic Susceptibility To Lung CancerNational Cancer Institute1996–2002
- Establishment Of A Familial Breast Cancer RegistryNational Cancer Institute1995–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: